skip to Global Navigation Bar skip to main content


homeHome > About Us > Company Profile > Introduction

Introduction

Established in 1945, Daewoong Pharmaceutical Co., Ltd. has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company by 2020.


In addition to its product portfolio, which includes 15 blockbuster products, Daewoong has built strong core competency for new drug development and has cultivated a cooperative culture for collaboration with global partners.


In the future, Daewoong will expand its global business with its foreign branches and global partners and become a global healthcare group which contributes to improving the quality of life for people worldwide.

General Informaion

  • • Stock Exchange Listing :KSE069620

  • • Sales :675 billion (dec.2013, KRW)

  • • Branches :14 (Korea) 7 (Asia) 1(America)

Sales Trend of Daewoong Pharmaceuticals Co

Unit : ´┐Žbillion

Net Profit (Unit : ´┐ŽBillion)
  • 03/2000 > 139
  • 03/2001 > 169
  • 03/2002 > 211
  • 03/2003 > 230
  • 03/2004> 248
  • 03/2005 > 280
  • 03/2006 > 338
  • 03/2007> 401
  • 03/2008> 484
  • 03/2009 > 548
  • 03/2010> 707
  • 12/2010 > 665